Risk factors associated with severe outcomes in adult hospitalized patients according to influenza type and subtype

PLoS ONE

Volumn 14, Issue 1, 2019, Pages

  Martínez, Ana ^a,b   Soldevila, Núria ^b,c   Romero Tamarit, Arantxa ^b   Torner, Núria ^a,b,c   Godoy, Pere ^a,b   Rius, Cristina ^b,d   Jané, Mireia ^a,b   Domínguez, Àngela ^b,c  

^a GENERALITAT DE CATALUNYA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL OUTCOME; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; FEMALE; HOSPITAL ADMISSION; HOSPITAL MORTALITY; HOSPITAL PATIENT; HUMAN; IMMUNE DEFICIENCY; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INTENSIVE CARE UNIT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; OBSERVATIONAL STUDY; ODDS RATIO; RISK FACTOR; SPAIN; ADOLESCENT; HOSPITALIZATION; INFLUENZA; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA B VIRUS; INTENSIVE CARE; MIDDLE AGED; MORTALITY; STATISTICAL MODEL; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; CRITICAL CARE; FEMALE; HOSPITALIZATION; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 85059842457     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0210353     Document Type: Article

References (39)

1. Treanor JJ. Influenza (including avian influenza and swine influenza). In: Bennett JE, Dolin R, Blaser MJ, editors. Principles and Practice of Infectious Diseases, 8th ed. Philadelphia: Elsevier; 2015. pp. 2000–2024.
2. WHO. Influenza (Seasonal). 31 Jan 2018. Available from: http://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal) Cited 7 September 2018.
3. Wright PF, Neuman G, Kawaoka Y. Othomyxoviruses. In: Knipe DM, Howley PM, editors. Fields Virology, 6th ed. Philadelphia: Wolters Kluwer; 2013. pp.1186–1243.
4. Breese JS, Fry AM, Sambhara S, Cox NJ. Inactivated influenza vaccines. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM, editors. Plotkin’s Vaccines, 7th ed. Philadelphia: Elsevier, 2018. pp. 456–488.
5. Ribas Freitas A, Donalisio MR. Excess of mortality in adults and elderly and circulation of subtypes of influenza virus in Southern Brazil. Front Immunol. 2018; 8:1903. https://doi.org/10.3389/fimmu.2017. 01903 PMID: 29375560
6. Su S, Chaves SS, Perez A, D’Mello T, Kirley PD, Yousey-Hindes K, et al. Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection. Clin Infect Dis. 2014; 59: 252–255. https://doi.org/10.1093/cid/ciu269 PMID: 24748521
7. Irving SA, Patel DC, Kieke BA, Donahue JG, Vandermause MF, Shay DK, et al. Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four season: 2004–2005 through 2007–2008. Influenza Other Respir Viruses. 2012; 6: 37–43. https://doi.org/10.1111/j.1750-2659.2011.00263.x PMID: 21668663
8. Yang SQ, Qu JX, Wang C, Yu XM, Liu YM, Cao B. Influenza pneumonia among adolescents and adults: a concurrent comparison between influenza A (H1N1) pdm09 and A (H3N2) in the post-pandemic period. Clin Respir J. 2014; 8: 185–191. https://doi.org/10.1111/crj.12056 PMID: 24106842
9. Loubet P, Samih-Lenzi N, Galtier F, Vanhems P, Loulergue P, Duval X, et al. Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter study. J Clin Virol. 2016; 79: 68–73. https://doi.org/10.1016/j.jcv.2016.04.005 PMID: 27105315
10. Mata-Marín LA, Mata-Marín JA, Vásquez-Mota VC, Arroyo-Anduiza CI, Gaytán-Martínez JE, Manjar-rez-Téllez B, et al. Risk factors associated with mortality in patients infected with influenza A/H1N1 in Mexico. BMC Res Notes. 2015; 8: 432. https://doi.org/10.1186/s13104-015-1349-8 PMID: 26362856
11. Rizzo C, Bella A. The impact of influenza virus B in Italy: myth or reality? J Prev Med Hyg. 2016; 57: E23–E27. PMID: 27346936
12. Chagvardieff A, Persico N, Marmillot C, Badiaga S, Charrel R, Roch A. Prospective comparative study of characteristics associated with influenza A and B in adults. Med Mal Infect 2018; 48: 180–187. https://doi.org/10.1016/j.medmal.2017.11.007 PMID: 29258804
13. Taylor G, Abdesselam K, Pelude L, Fernandes R, Mitchell R, McGeer A, et al. Epidemiological features of influenza in Canadian adult intensive care unit patients. Epidemiol Infect. 2016; 144: 741–750. https://doi.org/10.1017/S0950268815002113 PMID: 26384310
14. Caini S, Spreeuwenberg P, Kusznierz GF, Rudi JM, Owen R, Pennington K, et al. Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999–2014. BMC Infect Dis 2018; 18: 269. https://doi.org/10.1186/s12879-018-3181-y PMID: 29884140
15. Agència de Salut Pública de Catalunya. Pla d’actuació a Catalunya enfront d’una infecció per virus de la grip en fase post-pandèmica. 15 Jan 2018. Available from: http://canalsalut.gencat.cat/web/.content/home_canal_salut/professionals/temes_de_salut/grip/documents/grippostpan2010.pdf Cited 23 November 2018
16. Domínguez A, Romero-Tamarit A, Soldevila N, Godoy P, Jané M, Martínez A, et al. Effectiveness of antiviral treatment in preventing death in severe hospitalized influenza cases over six seasons. Epidemiol Infect. 2018; 146: 799–808. https://doi.org/10.1017/S0950268818000663 PMID: 29606178
17. Godoy P, Romero A, Soldevila N, Torner N, Jané M, Martínez A, et al. Influenza vaccine effectiveness in preventing influenza severity over six seasons from 2010/2011 to 2015/2016: a case-case analysis. Euro Surveill. 2018; 23: pii = 1700732.
18. Suwannakarn K, Payungporn S, Chieochansin T, Samransamruajkit R, Amonsin A, Songserm T, et al. Typing (A/B) and subtyping (H1/H3/H5) of influenza A viruses by multiplex real-time RT-PCR assays. J Virol Methods. 2008; 152: 25–31. https://doi.org/10.1016/j.jviromet.2008.06.002 PMID: 18598722
19. Katz MH. Multivariable analysis, 3rd ed. Cambridge: Cambridge University Press; 2011.
20. Decret 2013/2015, de 15 de setembre, pel qual es crea la Xarxa de Vigilància Epidemiològica i es regu-len els sistemes de notificació de malalties de declaració obligatòria i els brots epidèmics. DOGC 2015; núm 6958: 1–19.
21. Dwyer DE, Lynfield R, Losso MH, Davey RT, Cozzi-Lepri A, Wentworth D, et al. Comparison of the outcomes of individual with medically attended influenza A and B virus infections enrolled in 2 international cohort studies over a 6-year period: 2009–2015. Open Forum Infect Dis. 2017; 4: ofx212. https://doi.org/10.1093/ofid/ofx212 PMID: 29308401
22. Boddington NL, Verlander NQ, Pebody RG. Developing a system to estimate the severity of influenza infection in England: findings from a hospital-based surveillance system between 2010/2011 and 2014/ 2015. Epidemiol Infect 2017; 145: 1461–1470. https://doi.org/10.1017/S095026881700005X PMID: 28166855
23. Gutiérrez-Pizarraya A, Pérez-Romero P, Alvarez R, Aydillo TA, Osorio-Gómez G, Milara-Ibáñez C, et al. Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave. J Infect. 2012; 65: 423–430. https://doi.org/10.1016/j.jinf.2012.07.004PMID: 22820034
24. Álvarez-Lerma F, Marín-Corral J, Vilà C, Loeches IM, Barbadillo S, González de Molina FJ, et al. Characteristics of patients with hospital-acquired influenza A(H1N1)pdm09 virus admitted to the intensive care unit. J Hosp Infect. 2017; 95: 200–206. https://doi.org/10.1016/j.jhin.2016.12.017 PMID: 28153560
25. Lynfield R, Davey R, Dwyer DE, Losso MH, Wentworth D, Cozzi-Lepri A, et al. Outcomes of influenza A (H1N1)pdm09 virus infection: results from two international cohort studies. PLoS One. 2014; 9: e101785. https://doi.org/10.1371/journal.pone.0101785 PMID: 25004134
26. Lee N, Choi KW, Chan PK, Hui DS, Lui GC, Wong BC, et al. Outcomes of adults hospitalised with severe influenza. Thorax. 2010; 65: 510–515. https://doi.org/10.1136/thx.2009.130799 PMID: 20522848
27. Huang WT, Chang CH, Hsu YF, Chuang JH. Prognostic factors for mortality in patients hospitalized with influenza complications, in Taiwan. Int Health. 2015; 7: 73–75. https://doi.org/10.1093/inthealth/ ihu083 PMID: 25422279
28. Klein SL, Passaretti C, Anker M, Olukoya P, Pekosz A. The impact of sex, gender and pregnancy on 2009 H1N1 disease. Biol Sex Differ 2010; 1: 5. https://doi.org/10.1186/2042-6410-1-5 PMID: 21208468
29. Garg S, Jain S, Dawood FS, Jhung M, Pérez A, D’Mello T, et al. Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection-United States, 2005–2008. BMC Infect Dis. 2015; 15: 369. https://doi.org/10.1186/s12879-015-1004-y PMID: 26307108
30. Van Kerkhove MD, Cooper MJ, Eick-Cost AA, Sanchez JL, Riley S. Risk factors for severe outcomes among members of the United States military hospitalized with pneumonia and influenza, 2000–2012. Vaccine. 2015; 3: 6970–6976.
31. Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J, Mangino JE, et al. Severe influenza in 33 US hospitals, 2013–2014: complications and risk factors for death in 507 patients. Infect Control Hosp Epidemiol. 2015; 36: 1251–1260. https://doi.org/10.1017/ice.2015.170 PMID: 26224364
32. Ramos JM, García-Navarro MM, González de la Aleja MP, Sánchez-Martínez R, Gimeno-Gascón A, Reus S, et al. Seasonal influenza in octogenarians and nonagenarians admitted to a general hospital: epidemiology, clinical presentation and prognostic factors. Rev Esp Quimioter. 2016; 29: 296–301. PMID: 27714398
33. Braun ES, Crawford FW, Desai MM, Meek J, Kirley PD, Miller L, et al. Obesity not associated with severity among hospitalized adults with seasonal influenza virus infection. Infection 2015; 43: 569–575. https://doi.org/10.1007/s15010-015-0802-x PMID: 26148927
34. Sun Y, Wang Q, Yang G, Lin C, Zhang Y, Yang P. Weight and prognosis for influenza A(H1N1)pdm09 infection during the pandemic period between 2009 and 2011: a systematic review of observational studies with meta-analysis. Infect Dis. 2016; 48: 813–822.
35. Fedson DS. Clinically-initiated research on treating the host response to pandemic influenza. Hum Vac-cin Immunother. 2018; 14: 790–795. https://doi.org/10.1080/21645515.2017.1378292 PMID: 29058516
36. Mostaza JM, Lahoz C, García-Iglesias F, Estirado E, Ruiz-Rivas J, González-Alegre T, et al. Use of statins in primary prevention. Inf Ter Sist Nac Salud. 2011; 35: 46–56.
37. Cordero A, Rodríguez L, Batalla A, López L, Torres F, Castellano JM, et al. Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: results from the CAPS study. Cardiovasc Ther 2017; 35: e12240.
38. Ishiguro T, Takayanagi N, Kanauchi T, Uozumi R, Kawate E, Takaku Y, et al. Clinical and radiographic comparisons of influenza virus-associated pneumonia among three viral subtypes. Intern Med. 2016; 55: 731–737. https://doi.org/10.2169/internalmedicine.55.5227 PMID: 27041156
39. Cobbey S, Gouma S, Parkhouese K, Chambers B, Ertl HC, Scmader KE, et al. Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012–2013. Clin Infect Dis 2018; 67: 327–33. https://doi.org/10.1093/cid/ciy097 PMID: 29471464